Literature DB >> 32226831

Letter to the editor: Coffee consumption and bone health: A risk assessment.

Tomoyuki Kawada1.   

Abstract

Entities:  

Year:  2020        PMID: 32226831      PMCID: PMC7093679          DOI: 10.1016/j.afos.2020.02.005

Source DB:  PubMed          Journal:  Osteoporos Sarcopenia        ISSN: 2405-5255


× No keyword cloud information.
To the editor, I read the study by Coronado-Zarco et al. [1] with great interest. The authors conducted a systematic review on nonpharmacologic recommendations for osteoporosis treatment. Calcium and vitamin D intake, and exercise were mainly recommended. In addition, maintaining adequate protein intake, identification and treatment of risk factors for falls were also considered important. Furthermore, limiting the consumption of coffee, alcohol, and tobacco were presented. I have a concern about their review with special reference to coffee consumption in the older adults. As the authors pointed out, there were inconsistent results of the association. There is a lack of associations in women between coffee consumption and fracture [2] or bone information [3,4]. In addition, habitual coffee consumption is associated with lower risk of falling in older adults in Europe [5]. Furthermore, World Health Organization’s predictive scale for fracture (FRAX) does not include coffee consumption as a risk factor of fracture [6]. Taken together, risk of coffee consumption for osteoporosis should be handled with caution. Recently, Machado-Fragua et al. [7] investigated the association between coffee consumption and physical function impairment, frailty and disability in older women by considering obesity, hypertension or type 2 diabetes. Adjusted hazard ratio (HR) (95% confidence interval [CI]) of consumption of ≥2 cups of coffee/day for impaired agility was 0.71 (0.51–0.97), which was 0.60 (0.40–0.90) in women with obesity. In addition, adjusted HR (95% CI) of consumption of ≥2 cups of coffee/day for impaired mobility was 0.66 (0.46–0.95), which was 0.70 (0.48–1.00) in women with hypertension. Furthermore, adjusted HR (95% CI) of consumption of ≥2 cups of coffee/day for disability in activities of daily living among women with diabetes was 0.30 (0.11–0.76). Habitual coffee consumption seems beneficial in older women, especially having comorbid metabolic disorders.

Declaration of competing interest

No potential conflict of interest relevant to this article was reported.
  6 in total

1.  The influence of body size, smoking, and diet on bone density in pre- and postmenopausal women.

Authors:  S Franceschi; D Schinella; E Bidoli; L Dal Maso; C La Vecchia; F Parazzini; R Zecchin
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

2.  Dietary caffeine intake and bone status of postmenopausal women.

Authors:  T Lloyd; N Rollings; D F Eggli; K Kieselhorst; V M Chinchilli
Journal:  Am J Clin Nutr       Date:  1997-06       Impact factor: 7.045

3.  Habitual coffee consumption and risk of falls in 2 European cohorts of older adults.

Authors:  Marcos D Machado-Fragua; Ellen A Struijk; Juan-Manuel Ballesteros; Rosario Ortolá; Fernando Rodriguez-Artalejo; Esther Lopez-Garcia
Journal:  Am J Clin Nutr       Date:  2019-05-01       Impact factor: 7.045

4.  Coffee consumption and risk of physical function impairment, frailty and disability in older adults.

Authors:  Marcos D Machado-Fragua; Ellen A Struijk; Auxiliadora Graciani; Pilar Guallar-Castillon; Fernando Rodríguez-Artalejo; Esther Lopez-Garcia
Journal:  Eur J Nutr       Date:  2018-03-16       Impact factor: 5.614

5.  Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study.

Authors:  O Johnell; B Gullberg; J A Kanis; E Allander; L Elffors; J Dequeker; G Dilsen; C Gennari; A Lopes Vaz; G Lyritis
Journal:  J Bone Miner Res       Date:  1995-11       Impact factor: 6.741

Review 6.  Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines.

Authors:  Roberto Coronado-Zarco; Andrea Olascoaga-Gómez de León; Araceli García-Lara; Jimena Quinzaños-Fresnedo; Tania Inés Nava-Bringas; Salvador Israel Macías-Hernández
Journal:  Osteoporos Sarcopenia       Date:  2019-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.